Contact number
+33 1 81 69 15 00Chambers Review
McDermott Will & Emery is a well-reputed life sciences practice with a client base spanning domestic and foreign pharmaceutical companies, biotechnology developers and investment funds. The law firm provides a diverse range of advice encompassing research partnership agreements, licensing deals and medical technology development. The team frequently acts on cross-border cases.
Work Highlights
- McDermott advised Corteria Pharmaceuticals on its EUR65 million Series A fundraising.
Strengths
Provided by Chambers
"McDermott Will & Emery's team has solid experience handling complex matters and has the ability to think of creative solutions."
"The team is multidisciplinary and very efficient. The lawyers understand the specific needs of each file and provide tailor-made services."
"The firm is well known in the market; the team is experienced and with great reputation and track record. The firm also showed great synergy with its other offices, which is extremely useful."
"McDermott Will & Emery's team has solid experience handling complex matters and has the ability to think of creative solutions."
"The team is multidisciplinary and very efficient. The lawyers understand the specific needs of each file and provide tailor-made services."
"The firm is well known in the market; the team is experienced and with great reputation and track record. The firm also showed great synergy with its other offices, which is extremely useful."
Notable Practitioners
Emmanuelle Trombe is widely recognised as a leading corporate practitioner in the pharmaceutical and life sciences sectors, with outstanding expertise in acquisitions, financing rounds and licensing agreements.
"Emmanuelle Trombe is a real expert and has great knowledge of the industry, she is a very good lawyer."
"Emmanuelle has provided overall excellent service."
Anthony Paronneau boasts experience in M&A transactions and licensing matters. He is highly sought after by biotech startups.
"I am very lucky to have Anthony involved in this process, he is a calming force to have around, he allows the discussions to move forwards, keeps calm in all situations and he is a key asset for us."
"Anthony Paronneau is always very knowledgeable and delivers good advice."
Up-and-coming partner Anne-France Moreau joins the table thanks to her experience handling M&A mandates in the pharma sector, including private equity transactions.
"Anne-France is always available and pleasant even under pressure. It has been a great satisfaction working with her."
"Anne-France was able to understand complex subjects and bring it together to use in a legal context."